Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,095 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of cryoprotectants in hematopoietic cell infusion-related adverse events.
Ikeda K, Minakawa K, Yamahara K, Yamada-Fujiwara M, Okuyama Y, Fujiwara SI, Yamazaki R, Kanamori H, Iseki T, Nagamura-Inoue T, Kameda K, Nagai K, Fujii N, Ashida T, Hirose A, Takahashi T, Ohto H, Ueda K, Tanosaki R. Ikeda K, et al. Among authors: fujii n. Transfusion. 2022 Jun;62(6):1280-1288. doi: 10.1111/trf.16877. Epub 2022 Apr 9. Transfusion. 2022. PMID: 35396716
Peripheral blood circulating immature cell counts predict CD34+ cell yields in G-CSF-induced PBPC mobilization in healthy donors.
Kozuka T, Ikeda K, Teshima T, Yoshida C, Shinagawa K, Kojima K, Matsuo K, Bessho A, Sunami K, Hiramatsu Y, Maeda Y, Noguchi T, Yamamoto K, Fujii N, Imai T, Kusumoto KK, Masuda K, Takenaka K, Ishimaru F, Niiya K, Koide N, Tanimoto M, Harada M. Kozuka T, et al. Among authors: fujii n. Transfusion. 2004 Apr;44(4):526-32. doi: 10.1111/j.1537-2995.2004.03078.x. Transfusion. 2004. PMID: 15043568 Clinical Trial.
Adverse Events Associated With Infusion of Hematopoietic Stem Cell Products: A Prospective and Multicenter Surveillance Study.
Ikeda K, Ohto H, Okuyama Y, Yamada-Fujiwara M, Kanamori H, Fujiwara SI, Muroi K, Mori T, Kasama K, Iseki T, Nagamura-Inoue T, Fujii N, Ashida T, Kameda K, Kanda J, Hirose A, Takahashi T, Nagai K, Minakawa K, Tanosaki R. Ikeda K, et al. Among authors: fujii n. Transfus Med Rev. 2018 Jun 1:S0887-7963(18)30023-3. doi: 10.1016/j.tmrv.2018.05.005. Online ahead of print. Transfus Med Rev. 2018. PMID: 29891441 Free article. Review.
Efficacy of HLA virtual cross-matched platelet transfusions for platelet transfusion refractoriness in hematopoietic stem cell transplantation.
Seike K, Fujii N, Asano N, Ohkuma S, Hirata Y, Fujii K, Sando Y, Nakamura M, Naito K, Saeki K, Meguri Y, Asada N, Ennishi D, Nishimori H, Matsuoka KI, Tsubaki K, Otsuka F, Maeda Y. Seike K, et al. Among authors: fujii n, fujii k. Transfusion. 2020 Mar;60(3):473-478. doi: 10.1111/trf.15664. Epub 2020 Jan 22. Transfusion. 2020. PMID: 31970799
Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study.
Ikeda K, Ohto H, Yamada-Fujiwara M, Okuyama Y, Fujiwara SI, Muroi K, Mori T, Kasama K, Kanamori H, Iseki T, Nagamura-Inoue T, Kameda K, Kanda J, Nagai K, Fujii N, Ashida T, Hirose A, Takahashi T, Minakawa K, Tanosaki R. Ikeda K, et al. Among authors: fujii n. Transfusion. 2020 May;60(5):1015-1023. doi: 10.1111/trf.15786. Epub 2020 Apr 18. Transfusion. 2020. PMID: 32306410 Clinical Trial.
Effectiveness of supplemental oral calcium drink in preventing citrate-related adverse effects in peripheral blood progenitor cell collection.
Fujii K, Fujii N, Kondo T, Mitsuhashi T, Nakamura M, Seike K, Sando Y, Kimura M, Matsuda M, Ikegawa S, Sugiura H, Otsuka F, Maeda Y. Fujii K, et al. Among authors: fujii n. Transfus Apher Sci. 2021 Aug;60(4):103147. doi: 10.1016/j.transci.2021.103147. Epub 2021 Apr 24. Transfus Apher Sci. 2021. PMID: 33931360 Clinical Trial.
Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program.
Kanda Y, Inoue M, Uchida N, Onishi Y, Kamata R, Kotaki M, Kobayashi R, Tanaka J, Fukuda T, Fujii N, Miyamura K, Mori SI, Mori Y, Morishima Y, Yabe H, Kodera Y. Kanda Y, et al. Among authors: fujii n. Transplant Cell Ther. 2021 Aug;27(8):664.e1-664.e6. doi: 10.1016/j.jtct.2021.04.022. Epub 2021 May 5. Transplant Cell Ther. 2021. PMID: 33964514 Free PMC article.
Allo-anti-M: Detection peaks around 2 years of age, but may be attenuated by red blood cell transfusion.
Tamai Y, Ohto H, Yasuda H, Takeshita A, Fujii N, Ogo H, Yazawa Y, Hato T, Mitani K, Suzuki K, Yokohama A, Kato Y, Abe M, Kumagawa M, Ueda Y, Nollet KE, Cooling L, Kitazawa J; Pediatric RBC Alloimmunization Consortium. Tamai Y, et al. Among authors: fujii n. Transfusion. 2021 Sep;61(9):2718-2726. doi: 10.1111/trf.16594. Epub 2021 Jul 21. Transfusion. 2021. PMID: 34287925 Free PMC article.
2,095 results